Injection Mounjaro 5mg Vial of 0.5ml

Mounjaro 5 mg injection contains tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management. It is taken once a week and helps with weight loss and blood sugar control.Injectable medicine used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Tirzepatide acts on GIP and GLP-1 receptors to increase insulin release when blood sugar is high, reduce glucagon levels and slow gastric emptying.

Specifications:

• Manufactured by: Eli Lilly & Company India Pvt Ltd
• Combination: Tirzepatide Strength: 5 mg tirzepatide per 0.5 ml (10 mg/ml)​
• Dosage form: Solution for injection in single‑dose vial
• Route of administration: Subcutaneous use only (abdomen, thigh, or upper arm)​
• Dosing frequency: Once weekly, on the same day each week​
• Storage: Refrigerated at 2–8°C; do not freeze; protect from light​
• Shelf life: As printed on pack

How to use:

• Use only if prescribed and trained by a doctor or nurse.​

• Inject once a week, on the same day each week, at any time of day, with or without food.